Induction Healthcare Financials
| INHC Stock | 9.00 0.50 5.26% |
Operating Margin (0.62) | Profit Margin (0.31) | EPS Estimate Current Year (1.88) | Return On Equity (0.17) |
Induction | Select Account or Indicator |
Understanding current and past Induction Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Induction Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Induction Healthcare's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Induction Healthcare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Induction Healthcare Group. Check Induction Healthcare's Beneish M Score to see the likelihood of Induction Healthcare's management manipulating its earnings.
Induction Healthcare Stock Summary
Induction Healthcare competes with Prosiebensat, Catena Media, Taiwan Semiconductor, Melia Hotels, and Tata Steel. Induction Healthcare is entity of United Kingdom. It is traded as Stock on LSE exchange.| Foreign Associate | USA |
Specialization | Health Care, Health Care Equipment & Services |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB00BJ0M3545 |
| Business Address | 30 Crown Place, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.inductionhealthcare.com |
| Phone | 44 33 3939 8091 |
You should never invest in Induction Healthcare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Induction Stock, because this is throwing your money away. Analyzing the key information contained in Induction Healthcare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Induction Healthcare Key Financial Ratios
There are many critical financial ratios that Induction Healthcare's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Induction Healthcare reports annually and quarterly.| Revenue | 13.65 M | ||||
| Gross Profit | 4.99 M | ||||
| EBITDA | (165 K) | ||||
| Net Income | (3.26 M) | ||||
| Total Asset | 33.37 M |
Induction Healthcare Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 14.9M | 20.1M | 55.4M | 38.3M | 33.4M | 29.8M | |
| Other Current Liab | 1.8M | 828K | 2.5M | 2.7M | 4.3M | 2.3M | |
| Net Debt | (671K) | (872K) | (6.8M) | (4.2M) | (3.6M) | (3.8M) | |
| Retained Earnings | (6.2M) | (3.0M) | (2.1M) | (19.2M) | (22.5M) | (21.4M) | |
| Accounts Payable | 39K | 289K | 901K | 848K | 1.2M | 627.2K | |
| Cash | 671K | 872K | 7.0M | 4.3M | 3.7M | 3.1M | |
| Net Receivables | 156K | 878K | 3.7M | 5.0M | 4.9M | 2.7M | |
| Other Current Assets | 7K | 620K | 1.7M | 4.3M | 2.9M | 1.7M | |
| Total Liab | 2.4M | 3.7M | 13.1M | 14.0M | 13.0M | 9.1M | |
| Net Invested Capital | 12.4M | 16.5M | 42.3M | 24.3M | 20.4M | 21.2M | |
| Total Current Assets | 10.9M | 4.0M | 12.9M | 11.8M | 11.4M | 9.4M | |
| Capital Stock | 148K | 210K | 460K | 462K | 469K | 332.8K | |
| Net Working Capital | 8.8M | 1.5M | 6.1M | 5.3M | 5.2M | 4.4M | |
| Short Term Debt | 1.0 | (1.0M) | 72K | (1.7M) | 57K | 59.9K | |
| Intangible Assets | 3.9M | 15.3M | 40.7M | 25.9M | 11.2M | 17.8M | |
| Common Stock | 148K | 210K | 460K | 462K | 469K | 332.8K |
Induction Healthcare Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Gross Profit | (249K) | (622K) | 666K | 3.5M | 10.7M | 11.2M | |
| Operating Income | (3.3M) | (6.3M) | (8.6M) | (9.6M) | (4.2M) | (4.4M) | |
| Ebit | (3.5M) | (8.1M) | (9.1M) | (17.4M) | (4.2M) | (4.4M) | |
| Research Development | 962K | 1.9M | 5.3M | 9.3M | 8.8M | 5.0M | |
| Ebitda | (3.2M) | (6.8M) | (5.3M) | (12.7M) | (165K) | (173.3K) | |
| Cost Of Revenue | 397K | 2.0M | 6.6M | 9.4M | 2.9M | 3.9M | |
| Income Before Tax | (3.5M) | (8.1M) | (9.2M) | (17.4M) | (4.2M) | (4.4M) | |
| Net Income | (3.5M) | (7.6M) | (8.4M) | (17.4M) | (3.3M) | (3.4M) | |
| Income Tax Expense | 152.1K | (503K) | (1.1M) | (798K) | (962K) | (913.9K) |
Induction Healthcare Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 502K | 201K | 6.1M | (2.7M) | (597K) | (567.2K) | |
| Free Cash Flow | (4.1M) | (5.7M) | (5.4M) | (3.6M) | (1.4M) | (1.5M) | |
| Depreciation | 324K | 1.3M | 3.8M | 4.6M | 4.0M | 2.6M | |
| Other Non Cash Items | 1.1M | 1.0M | 4.3M | 12.1M | (569.0K) | (540.5K) | |
| Capital Expenditures | 761K | 1.7M | 3.3M | 827K | 329K | 312.6K | |
| Net Income | (3.5M) | (7.6M) | (8.1M) | (16.6M) | (3.3M) | (3.4M) | |
| End Period Cash Flow | 671K | 872K | 7.0M | 4.3M | 3.7M | 3.1M |
Induction Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Induction Healthcare's current stock value. Our valuation model uses many indicators to compare Induction Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Induction Healthcare competition to find correlations between indicators driving Induction Healthcare's intrinsic value. More Info.Induction Healthcare Group is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Induction Healthcare's earnings, one of the primary drivers of an investment's value.Induction Healthcare Systematic Risk
Induction Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Induction Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Induction Healthcare correlated with the market. If Beta is less than 0 Induction Healthcare generally moves in the opposite direction as compared to the market. If Induction Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Induction Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Induction Healthcare is generally in the same direction as the market. If Beta > 1 Induction Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Induction Healthcare Group Total Assets Over Time
Induction Healthcare Thematic Clasifications
Induction Healthcare Group is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
| Health Management | View |
Induction Healthcare November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Induction Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Induction Healthcare Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Induction Healthcare Group based on widely used predictive technical indicators. In general, we focus on analyzing Induction Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Induction Healthcare's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 18.6 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 7.14 |
Additional Tools for Induction Stock Analysis
When running Induction Healthcare's price analysis, check to measure Induction Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Induction Healthcare is operating at the current time. Most of Induction Healthcare's value examination focuses on studying past and present price action to predict the probability of Induction Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Induction Healthcare's price. Additionally, you may evaluate how the addition of Induction Healthcare to your portfolios can decrease your overall portfolio volatility.